Michaelis, Martin

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

Michaelis, M., Rothweiler, F., Barth, S., Cinatl, J., van Rikxoort, M., Löschmann, N., Voges, Y., Breitling, R., von Deimling, A., Rödel, F., et al. (2011) · Cell Death & Disease

Cancer-related Molecular PathwaysDrug Transport and Resistance Mechanisms

Cited by 190

Novel swine-origin influenza A virus in humans: another pandemic knocking at the door.

Michaelis, M., Doerr, H. W., & Cinatl, J. (2009) · Medical Microbiology and Immunology

Influenza Virus Research StudiesRespiratory viral infections research

Cited by 127

Environmental conditions shape the nature of a minimal bacterial genome

Antczak, M., Michaelis, M., & Wass, M. N. (2019) · Nature Communications

Genomics and Phylogenetic StudiesBacterial Genetics and Biotechnology

Cited by 55

Resistance acquisition to MDM2 inhibitors

Cinatl, J., Speidel, D., Hardcastle, I., & Michaelis, M. (2014) · Biochemical Society Transactions

Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 30

Intact-cell MALDI-ToF mass spectrometry for the authentication of drug-adapted cancer cell lines

Povey, J. F., Saintas, E., Aderemi, A. V., Rothweiler, F., Zehner, R., Dirks, W. G., Cinatl, J., Racher, A. J., Wass, M. N., Smales, C. M., et al. (2019) · Cells

Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and Applications

Cited by 5